JLJulio C. Y. Liu

Julio C. Y. Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Julio C. Y. Liu has a total of 30 co-authors. Here are the top co-authors by number of shared publications:

  • Niels Mailand

    Novo Nordisk Foundation Center for Protein Research, Department of Cellular and Molecular Medicine, University of Copenhagen, 2200, Copenhagen, Denmark.

    3 shared publications
  • Ronald Thomas Hay

    Division of Molecular, Cellular and Developmental Biology, School of Life Sciences, University of Dundee, Dow Street, Dundee DD1 5EH, UK

    3 shared publications
  • Ivo Alexander Hendriks

    Proteomics Program, Novo Nordisk Foundation Center for Protein Research, Department of Cellular and Molecular Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

    2 shared publications
  • Leena Ackermann

    Protein Signaling Program, Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark

    2 shared publications
  • Michael H. Tatham

    Division of Molecular, Cell and Developmental Biology, School of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K.

    2 shared publications
  • Peter Haahr

    Center for Gene Expression, Department of Cellular and Molecular Medicine, Faculty of Health, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen N, Denmark

    2 shared publications

Latest Publications

  • Open Access

    PML mutants from arsenic-resistant patients reveal SUMO1-TOPORS and SUMO2/3-RNF4 degradation pathways

    by Ellis G. Jaffray, Michael H. Tatham, Barbara Mojsa, Anna Plechanovová, Alejandro Rojas-Fernandez, Julio C.Y. Liu, Niels Mailand, Adel F.M. Ibrahim, Graeme Ball, Iain M. Porter, et al.

    Arsenic effectively treats acute promyelocytic leukemia by inducing SUMO and ubiquitin-dependent degradation of the promyelocytic leukemia (PML)–retinoic acid receptor alpha oncogenic fusion protein. However, some patients relapse with arsenic-resistant disease because of missense mutations in PML. To determine the mechanistic basis for arsenic resistance, PML−/− cells were reconstituted with YFP fusions of wild-type PML-V and two common patient mutants: A216T and L217F. Both mutants were resistant to degradation by arsenic but for different biochemical reasons. Arsenic did not trigger SUMOylation of A216T PML, which failed to recruit the SUMO-targeting ubiquitin ligases RNF4 and TOPORS. L217F PML did respond with increased SUMO2/3 conjugation that facilitated RNF4 engagement but failed to reach the threshold of SUMO1 conjugation required to recruit TOPORS. Thus, neither mutant accumulated the appropriate polyubiquitin signal required for p97 binding. These PML mutants have revealed a convergence of SUMO1, SUMO2/3, TOPORS, and RNF4 that facilitates the arsenic-induced degradation of PML.


  • Open Access

    Concerted SUMO-targeted ubiquitin ligase activities of TOPORS and RNF4 are essential for stress management and cell proliferation

    by Julio C. Y. Liu, Leena Ackermann, Saskia Hoffmann, Zita Gál, Ivo A. Hendriks, Charu Jain, Louise Morlot, Michael H. Tatham, Gian-Luca McLelland, Ronald T. Hay, et al.

    Protein SUMOylation provides a principal driving force for cellular stress responses, including DNA–protein crosslink (DPC) repair and arsenic-induced PML body degradation. In this study, using genome-scale screens, we identified the human E3 ligase TOPORS as a key effector of SUMO-dependent DPC resolution. We demonstrate that TOPORS promotes DPC repair by functioning as a SUMO-targeted ubiquitin ligase (STUbL), combining ubiquitin ligase activity through its RING domain with poly-SUMO binding via SUMO-interacting motifs, analogous to the STUbL RNF4. Mechanistically, TOPORS is a SUMO1-selective STUbL that complements RNF4 in generating complex ubiquitin landscapes on SUMOylated targets, including DPCs and PML, stimulating efficient p97/VCP unfoldase recruitment and proteasomal degradation. Combined loss of TOPORS and RNF4 is synthetic lethal even in unstressed cells, involving defective clearance of SUMOylated proteins from chromatin accompanied by cell cycle arrest and apoptosis. Our findings establish TOPORS as a STUbL whose parallel action with RNF4 defines a general mechanistic principle in crucial cellular processes governed by direct SUMO–ubiquitin crosstalk.


  • Open Access

    Mechanism and function of DNA replication‐independent DNA‐protein crosslink repair via the SUMO‐RNF4 pathway

    by Julio C Y Liu, Ulrike Kühbacher, Nicolai B Larsen, Nikoline Borgermann, Dimitriya H Garvanska, Ivo A Hendriks, Leena Ackermann, Peter Haahr, Irene Gallina, Claire Guérillon, et al.

    EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.